Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 4 Results

Title
Intervention Indication Therapeutic Area Year Actions
Subcutaneous Tocilizumab (RoACTEMRA) With or Without Methotrexate for the Treatment of Inadequate Responders in Systemic Juvenile Idiopathic Arthritis Methotrexate (MTX; Otrexup; Vibex MTX; MQX-5902; methotrexate disodium; methotrexate sodium) , Tocilizumab (Actemra; R1569; RoActemra) Juvenile idiopathic arthritis Rheumatology 2017 View  |  Download
Tocilizumab (RoACTEMRA) [subcutaneous injection with an auto injector device] for adult patients with moderate to severe active rheumatoid arthritis - after DMARD failure Tocilizumab (Actemra; R1569; RoActemra) Rheumatoid arthritis Rheumatology 2017 View  |  Download
Tocilizumab (RoActemra) for Adults with Giant Cell Arteritis - intravenous injection Tocilizumab (Actemra; R1569; RoActemra) Giant cell arteritis Cardiovascular System 2018 View  |  Download
Tocilizumab (RoActemra) for Adults with Systemic Sclerosis – Second Line Tocilizumab (Actemra; R1569; RoActemra) Systemic sclerosis Dermatology , Respiratory System 2017 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications